Question 1

What are the potential side effects of Gemcitabine compared to UFT?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial fit with my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the chances that I will benefit from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I have access to support services during my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer clinical trial (NCT00139971). Contact the study team or your healthcare provider for specific answers.

What this study is about